GlaxoSmithKline Biologicals: world's leading vaccine manufacturer with a strong focus on (combined) paediatric vaccines

Link to Internet site: www.gsk-bio.com

GlaxoSmithKline Biologicals (GSK Biologicals), the world's leading vaccine manufacturer, is located in Rixensart, Belgium. Belgium is the centre of all GlaxoSmithKlineís activities in the field of vaccine research, development and production. GSK Biologicals employs more than 1000 research scientists who are devoted to discovering new vaccines and developing more cost-effective and convenient combination products to prevent infections that cause serious medical problems worldwide. In 2002, an average of 25 GSK Biologicals vaccine doses per second were delivered to 156 countries in both the industrialised and developing world. 100 million of the 800 million plus vaccine doses delivered last year were combined paediatric vaccines that protect the worldís children against a minimum of 3 and up to 6 diseases in one go.
For information, visit GSK Biologicals' vaccines website site at www.worldwidevaccines.com.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.